Skip to main content
Erschienen in: Supportive Care in Cancer 4/2015

01.04.2015 | Original Article

A mindfulness-based program for improving quality of life among hematopoietic stem cell transplantation survivors: feasibility and preliminary findings

verfasst von: Paul Grossman, Diana Zwahlen, Jorg P. Halter, Jakob R. Passweg, Claudia Steiner, Alexander Kiss

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Health-related quality of life (HRQoL) is often substantially reduced among individuals who have undergone hematopoietic stem cell transplantation (HSCT), and incidences of depression, fatigue, and anxiety are elevated. We examined effects of a mindfulness-based intervention (MBI) compared to psycho-oncological telephone consultation upon HRQoL, depression, anxiety, and fatigue among HSCT survivors. Sixty-two medically stable patients participated in the study; they had completed HSCT ≥6 months previously. Thirty-two were randomly assigned to intervention arms, and 30 were offered their treatment preference. MBI consisted of a structured 8-week program of mindfulness training. Assessments were made at baseline, post-intervention and 3 months follow-up. Primary outcome was HRQoL. Depression, fatigue, anxiety, and personal goal attainment were secondary measures. Non-completion of interventions was low in both groups (9 %, MBI; 7 % control). Employing intention-to-treat analysis, MBI, compared with comparison procedure, improved HRQoL and reduced depression and anxiety at post-intervention (p’s < 0.05); Cohen’s d effect sizes, 0.6–0.7; 3-month follow-up benefits were modest. These findings demonstrate broad feasibility and acceptance of, as well as satisfaction and adherence with, a program of mindfulness training for HSCT survivors; findings also suggest improved HRQoL and well-being as a consequence of MBI. Nevertheless, this is a preliminary study; a larger trial with more prolonged intervention phase is warranted.
Literatur
1.
Zurück zum Zitat Carlson LE, Doll R, Stephen J, Faris P, Tamagawa R, Drysdale E et al (2013) Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer. J Clin Oncol 31(25):3119–3126CrossRefPubMed Carlson LE, Doll R, Stephen J, Faris P, Tamagawa R, Drysdale E et al (2013) Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer. J Clin Oncol 31(25):3119–3126CrossRefPubMed
2.
Zurück zum Zitat Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW (2012) Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial. J Clin Oncol 30(12):1335–1342CrossRefPubMed Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW (2012) Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial. J Clin Oncol 30(12):1335–1342CrossRefPubMed
3.
Zurück zum Zitat Wurtzen H, Dalton SO, Elsass P, Sumbundu AD, Steding-Jensen M, Karlsen RV et al (2013) Mindfulness significantly reduces self-reported levels of anxiety and depression: results of a randomised controlled trial among 336 Danish women treated for stage I-III breast cancer. Eur J Cancer 49(6):1365–1373CrossRefPubMed Wurtzen H, Dalton SO, Elsass P, Sumbundu AD, Steding-Jensen M, Karlsen RV et al (2013) Mindfulness significantly reduces self-reported levels of anxiety and depression: results of a randomised controlled trial among 336 Danish women treated for stage I-III breast cancer. Eur J Cancer 49(6):1365–1373CrossRefPubMed
4.
Zurück zum Zitat Carlson LE, Ursuliak Z, Goodey E, Angen M, Speca M (2001) The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up. Support Care Cancer 9(2):112–123CrossRefPubMed Carlson LE, Ursuliak Z, Goodey E, Angen M, Speca M (2001) The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up. Support Care Cancer 9(2):112–123CrossRefPubMed
5.
Zurück zum Zitat Speca M, Carlson LE, Goodey E, Angen M (2000) A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 62(5):613–622CrossRefPubMed Speca M, Carlson LE, Goodey E, Angen M (2000) A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 62(5):613–622CrossRefPubMed
6.
Zurück zum Zitat Bauer-Wu S, Sullivan AM, Rosenbaum E, Ott MJ, Powell M, McLoughlin M et al (2008) Facing the challenges of hematopoietic stem cell transplantation with mindfulness meditation: a pilot study. Integr Cancer Ther 7(2):62–69CrossRefPubMed Bauer-Wu S, Sullivan AM, Rosenbaum E, Ott MJ, Powell M, McLoughlin M et al (2008) Facing the challenges of hematopoietic stem cell transplantation with mindfulness meditation: a pilot study. Integr Cancer Ther 7(2):62–69CrossRefPubMed
7.
Zurück zum Zitat McArdle JR (2009) Critical care outcomes in the hematologic transplant recipient. Clin Chest Med 30(1):155–167CrossRefPubMed McArdle JR (2009) Critical care outcomes in the hematologic transplant recipient. Clin Chest Med 30(1):155–167CrossRefPubMed
8.
Zurück zum Zitat Michlitsch JG, Walters MC (2008) Recent advances in bone marrow transplantation in hemoglobinopathies. Curr Mol Med 8(7):675–689CrossRefPubMed Michlitsch JG, Walters MC (2008) Recent advances in bone marrow transplantation in hemoglobinopathies. Curr Mol Med 8(7):675–689CrossRefPubMed
9.
Zurück zum Zitat Porta F, Locatelli F, Burgio GR (2008) Hematopoietic stem cell transplantation: 40 years of continuous progress and evolution. Haematologica 93(11):1607–1610CrossRefPubMed Porta F, Locatelli F, Burgio GR (2008) Hematopoietic stem cell transplantation: 40 years of continuous progress and evolution. Haematologica 93(11):1607–1610CrossRefPubMed
12.
Zurück zum Zitat Gratwohl A (2002) New developments in hematopoietic stem cell transplantation. Ther Umsch 59(11):571–6CrossRefPubMed Gratwohl A (2002) New developments in hematopoietic stem cell transplantation. Ther Umsch 59(11):571–6CrossRefPubMed
13.
Zurück zum Zitat Passweg J, Baldomero H, Chapuis B, Leibundgut K, Schanz U, Gratwohl A (2006) Haematopoietic stem cell transplantation in Switzerland. Report from the Swiss Transplant Working Group Blood and Marrow Transplantation (STABMT) Registry 1997–2003. Swiss Med Wkly 136(3–4):50–58PubMed Passweg J, Baldomero H, Chapuis B, Leibundgut K, Schanz U, Gratwohl A (2006) Haematopoietic stem cell transplantation in Switzerland. Report from the Swiss Transplant Working Group Blood and Marrow Transplantation (STABMT) Registry 1997–2003. Swiss Med Wkly 136(3–4):50–58PubMed
14.
Zurück zum Zitat Carlson LE, Smith D, Russell J, Fibich C, Whittaker T (2006) Individualized exercise program for the treatment of severe fatigue in patients after allogeneic hematopoietic stem-cell transplant: a pilot study. Bone Marrow Transplant 37(10):945–954CrossRefPubMed Carlson LE, Smith D, Russell J, Fibich C, Whittaker T (2006) Individualized exercise program for the treatment of severe fatigue in patients after allogeneic hematopoietic stem-cell transplant: a pilot study. Bone Marrow Transplant 37(10):945–954CrossRefPubMed
15.
Zurück zum Zitat Carr D, Goudas L, Lawrence D et al (2002) Management of cancer symptoms: pain, depression, and fatigue. Agency for Healthcare Research and Quality, Rockville, MD Carr D, Goudas L, Lawrence D et al (2002) Management of cancer symptoms: pain, depression, and fatigue. Agency for Healthcare Research and Quality, Rockville, MD
16.
Zurück zum Zitat Butt Z, Rosenbloom SK, Abernethy AP, Beaumont JL, Paul D, Hampton D et al (2008) Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw 6(5):448–455PubMed Butt Z, Rosenbloom SK, Abernethy AP, Beaumont JL, Paul D, Hampton D et al (2008) Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw 6(5):448–455PubMed
17.
Zurück zum Zitat Syrjala KL, Kurland BF, Abrams JR, Sanders JE, Heiman JR (2008) Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood 111(3):989–996CrossRefPubMedCentralPubMed Syrjala KL, Kurland BF, Abrams JR, Sanders JE, Heiman JR (2008) Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood 111(3):989–996CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Tichelli A, Rovo A, Gratwohl A (2008) Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. Hematol Am Soc Hematol Educ Program 2008:125–133CrossRef Tichelli A, Rovo A, Gratwohl A (2008) Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. Hematol Am Soc Hematol Educ Program 2008:125–133CrossRef
19.
Zurück zum Zitat Rovo A, Daikeler T, Stern M, Halter J, Studt JD, Buser A et al (2008) Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood 111(3):1740–1741CrossRefPubMed Rovo A, Daikeler T, Stern M, Halter J, Studt JD, Buser A et al (2008) Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood 111(3):1740–1741CrossRefPubMed
20.
Zurück zum Zitat Tichelli A, Bucher C, Rovo A, Stussi G, Stern M, Paulussen M et al (2007) Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 110(9):3463–3471CrossRefPubMed Tichelli A, Bucher C, Rovo A, Stussi G, Stern M, Paulussen M et al (2007) Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 110(9):3463–3471CrossRefPubMed
21.
Zurück zum Zitat Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H et al (2004) A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant 34:257–266CrossRefPubMed Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H et al (2004) A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant 34:257–266CrossRefPubMed
22.
Zurück zum Zitat Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112(11 Suppl):2577–2592CrossRefPubMed Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112(11 Suppl):2577–2592CrossRefPubMed
23.
Zurück zum Zitat Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M et al (2005) Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 105(11):4215–4222CrossRefPubMedCentralPubMed Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M et al (2005) Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 105(11):4215–4222CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG et al (2007) Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110(10):3784–3792CrossRefPubMedCentralPubMed Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG et al (2007) Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110(10):3784–3792CrossRefPubMedCentralPubMed
25.
Zurück zum Zitat Khera N, Storer B, Flowers ME, Carpenter PA, Inamoto Y, Sandmaier BM et al (2012) Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol 30(1):71–77CrossRefPubMedCentralPubMed Khera N, Storer B, Flowers ME, Carpenter PA, Inamoto Y, Sandmaier BM et al (2012) Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol 30(1):71–77CrossRefPubMedCentralPubMed
26.
Zurück zum Zitat Ness KK, Bhatia S, Baker KS, Francisco L, Carter A, Forman SJ et al (2005) Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study. Arch Pediatr Adolesc Med 159(8):706–713CrossRefPubMed Ness KK, Bhatia S, Baker KS, Francisco L, Carter A, Forman SJ et al (2005) Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study. Arch Pediatr Adolesc Med 159(8):706–713CrossRefPubMed
27.
Zurück zum Zitat Norkin M, Hsu JW, Wingard JR (2012) Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation. Semin Hematol 49(1):104–109CrossRefPubMed Norkin M, Hsu JW, Wingard JR (2012) Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation. Semin Hematol 49(1):104–109CrossRefPubMed
28.
Zurück zum Zitat Shanis D, Merideth M, Pulanic TK, Savani BN, Battiwalla M, Stratton P (2012) Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management. Semin Hematol 49(1):83–93CrossRefPubMedCentralPubMed Shanis D, Merideth M, Pulanic TK, Savani BN, Battiwalla M, Stratton P (2012) Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management. Semin Hematol 49(1):83–93CrossRefPubMedCentralPubMed
29.
Zurück zum Zitat Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S (2011) Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood 118(17):4723–4731CrossRefPubMedCentralPubMed Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S (2011) Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood 118(17):4723–4731CrossRefPubMedCentralPubMed
30.
Zurück zum Zitat Bevans MF, Mitchell SA, Barrett J, Bishop MR, Childs R, Fowler D et al (2013) Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors. Biol Blood Marrow Transplant 20(3):387–395CrossRefPubMed Bevans MF, Mitchell SA, Barrett J, Bishop MR, Childs R, Fowler D et al (2013) Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors. Biol Blood Marrow Transplant 20(3):387–395CrossRefPubMed
31.
Zurück zum Zitat Mitchell AJ, Benito-Leon J, Gonzalez JM, Rivera-Navarro J (2005) Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 4(9):556–566CrossRefPubMed Mitchell AJ, Benito-Leon J, Gonzalez JM, Rivera-Navarro J (2005) Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 4(9):556–566CrossRefPubMed
32.
Zurück zum Zitat Mosher CE, Redd WH, Rini CM, Burkhalter JE, Duhamel KN (2008) Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 18(2):113–127CrossRef Mosher CE, Redd WH, Rini CM, Burkhalter JE, Duhamel KN (2008) Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 18(2):113–127CrossRef
33.
Zurück zum Zitat Wiskemann J, Huber G (2008) Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 41(4):321–329CrossRefPubMed Wiskemann J, Huber G (2008) Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 41(4):321–329CrossRefPubMed
34.
Zurück zum Zitat Kim SD, Kim HS (2005) Effects of a relaxation breathing exercise on anxiety, depression, and leukocyte in hemopoietic stem cell transplantation patients. Cancer Nurs 28(1):79–83CrossRefPubMed Kim SD, Kim HS (2005) Effects of a relaxation breathing exercise on anxiety, depression, and leukocyte in hemopoietic stem cell transplantation patients. Cancer Nurs 28(1):79–83CrossRefPubMed
35.
Zurück zum Zitat Kim SD, Kim HS (2005) Effects of a relaxation breathing exercise on fatigue in haemopoietic stem cell transplantation patients. J Clin Nurs 14:51–55CrossRefPubMed Kim SD, Kim HS (2005) Effects of a relaxation breathing exercise on fatigue in haemopoietic stem cell transplantation patients. J Clin Nurs 14:51–55CrossRefPubMed
36.
Zurück zum Zitat DuHamel KN, Mosher CE, Winkel G, Labay LE, Rini C, Meschian YM et al (2010) Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. J Clin Oncol 28(23):3754–3761CrossRefPubMedCentralPubMed DuHamel KN, Mosher CE, Winkel G, Labay LE, Rini C, Meschian YM et al (2010) Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. J Clin Oncol 28(23):3754–3761CrossRefPubMedCentralPubMed
37.
Zurück zum Zitat Mock V (2004) Evidence-based treatment for cancer-related fatigue. J Nat Cancer Inst Monographs 32:112–118CrossRef Mock V (2004) Evidence-based treatment for cancer-related fatigue. J Nat Cancer Inst Monographs 32:112–118CrossRef
38.
Zurück zum Zitat Hoodin F, Uberti JP, Lynch TJ, Steele P, Ratanatharathorn V (2006) Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant 38(4):255–264CrossRefPubMed Hoodin F, Uberti JP, Lynch TJ, Steele P, Ratanatharathorn V (2006) Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant 38(4):255–264CrossRefPubMed
39.
Zurück zum Zitat Akaho R, Sasaki T, Mori S-I, Akiyama H, Yoshino M, Hagiya K et al (2003) Psychological factors and survival after bone marrow transplantation in patients with leukemia. Psychiatry Clin Neurosci 57(1):91–96CrossRefPubMed Akaho R, Sasaki T, Mori S-I, Akiyama H, Yoshino M, Hagiya K et al (2003) Psychological factors and survival after bone marrow transplantation in patients with leukemia. Psychiatry Clin Neurosci 57(1):91–96CrossRefPubMed
40.
Zurück zum Zitat Hochhausen N, Altmaier EM, McQuellon R, Davies SM, Papadopolous E, Carter S et al (2007) Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation. J Psychosoc Oncol 25(1):87–101CrossRefPubMed Hochhausen N, Altmaier EM, McQuellon R, Davies SM, Papadopolous E, Carter S et al (2007) Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation. J Psychosoc Oncol 25(1):87–101CrossRefPubMed
41.
Zurück zum Zitat Jenks Kettmann JD, Altmaier EM (2008) Social support and depression among bone marrow transplant patients. J Health Psychol 13(1):39–46CrossRefPubMed Jenks Kettmann JD, Altmaier EM (2008) Social support and depression among bone marrow transplant patients. J Health Psychol 13(1):39–46CrossRefPubMed
42.
Zurück zum Zitat Grossman P, Niemann L, Schmidt S, Walach H (2004) Mindfulness-based stress reduction and health benefits: a meta-analysis. J Psychosom Res 57(1):35–43CrossRefPubMed Grossman P, Niemann L, Schmidt S, Walach H (2004) Mindfulness-based stress reduction and health benefits: a meta-analysis. J Psychosom Res 57(1):35–43CrossRefPubMed
43.
Zurück zum Zitat Kabat-Zinn J. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain and Illness. Revised Edition New York: Delacorte; 2013. Kabat-Zinn J. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain and Illness. Revised Edition New York: Delacorte; 2013.
44.
Zurück zum Zitat Grossman P, Kappos L, Gensicke H, D’Souza M, Mohr DC, Penner IK et al (2010) MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology 75(13):1141–1149CrossRefPubMedCentralPubMed Grossman P, Kappos L, Gensicke H, D’Souza M, Mohr DC, Penner IK et al (2010) MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology 75(13):1141–1149CrossRefPubMedCentralPubMed
45.
Zurück zum Zitat Beaver K, Tysver-Robinson D, Campbell M, Twomey M, Williamson S, Hindley A et al (2009) Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ 338:a3147CrossRefPubMedCentralPubMed Beaver K, Tysver-Robinson D, Campbell M, Twomey M, Williamson S, Hindley A et al (2009) Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ 338:a3147CrossRefPubMedCentralPubMed
46.
Zurück zum Zitat Chamberlain Wilmoth M, Tulman L, Coleman EA, Stewart CB, Samarel N (2006) Women’s perceptions of the effectiveness of telephone support and education on their adjustment to breast cancer. Oncol Nurs Forum 33(1):138–144CrossRefPubMed Chamberlain Wilmoth M, Tulman L, Coleman EA, Stewart CB, Samarel N (2006) Women’s perceptions of the effectiveness of telephone support and education on their adjustment to breast cancer. Oncol Nurs Forum 33(1):138–144CrossRefPubMed
47.
Zurück zum Zitat Chumbler NR, Mkanta WN, Richardson LC, Harris L, Darkins A, Kobb R et al (2007) Remote patient-provider communication and quality of life: empirical test of a dialogic model of cancer care. J Telemed Telecare 13(1):20–25CrossRefPubMed Chumbler NR, Mkanta WN, Richardson LC, Harris L, Darkins A, Kobb R et al (2007) Remote patient-provider communication and quality of life: empirical test of a dialogic model of cancer care. J Telemed Telecare 13(1):20–25CrossRefPubMed
48.
Zurück zum Zitat Coleman EA, Tulman L, Samarel N, Wilmoth MC, Rickel L, Rickel M et al (2005) The effect of telephone social support and education on adaptation to breast cancer during the year following diagnosis. Oncol Nurs Forum 32(4):822–829CrossRefPubMed Coleman EA, Tulman L, Samarel N, Wilmoth MC, Rickel L, Rickel M et al (2005) The effect of telephone social support and education on adaptation to breast cancer during the year following diagnosis. Oncol Nurs Forum 32(4):822–829CrossRefPubMed
49.
Zurück zum Zitat Siegrist J, Broer M, Junge A (1996) Profil der Lebensqualität chronisch Kranker. Manual. [Profile of Quality of Life for the Chronically Ill]. Beltz Test, Göttingen Siegrist J, Broer M, Junge A (1996) Profil der Lebensqualität chronisch Kranker. Manual. [Profile of Quality of Life for the Chronically Ill]. Beltz Test, Göttingen
50.
Zurück zum Zitat Hart S, Fonareva I, Merluzzi N, Mohr DC (2005) Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. Qual Life Res 14(3):695–703CrossRefPubMed Hart S, Fonareva I, Merluzzi N, Mohr DC (2005) Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. Qual Life Res 14(3):695–703CrossRefPubMed
51.
Zurück zum Zitat Grossman P, Tiefenthaler U, Raysz A, Kesper U (2007) Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother Psychosom 76(4):226–233CrossRefPubMed Grossman P, Tiefenthaler U, Raysz A, Kesper U (2007) Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother Psychosom 76(4):226–233CrossRefPubMed
52.
Zurück zum Zitat Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed
53.
Zurück zum Zitat Victorson D, Barocas J, Song J, Cella D (2008) Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization. Qual Life Res 17(9):1137–1146CrossRefPubMed Victorson D, Barocas J, Song J, Cella D (2008) Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization. Qual Life Res 17(9):1137–1146CrossRefPubMed
54.
Zurück zum Zitat Hautzinger M, Bailer M (1991) Allgemeine Depressionsskala (ADS). Die deutsche Version des CES-D. Weinheim, Beltz Hautzinger M, Bailer M (1991) Allgemeine Depressionsskala (ADS). Die deutsche Version des CES-D. Weinheim, Beltz
55.
Zurück zum Zitat Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef
56.
Zurück zum Zitat Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D et al (1993) Development of a fatigue scale. J Psychosom Res 37(2):147–153CrossRefPubMed Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D et al (1993) Development of a fatigue scale. J Psychosom Res 37(2):147–153CrossRefPubMed
57.
Zurück zum Zitat Cohen J (1988) Statistical power analysis for the behavioral sciences. Academic, New York Cohen J (1988) Statistical power analysis for the behavioral sciences. Academic, New York
58.
Zurück zum Zitat Schmoor C, Olschewski M, Schumacher M (1996) Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies. Stat Med 15:263–271CrossRefPubMed Schmoor C, Olschewski M, Schumacher M (1996) Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies. Stat Med 15:263–271CrossRefPubMed
59.
Zurück zum Zitat Lin P, Campbell DG, Chaney EF, Liu CF, Heagerty P, Felker BL et al (2005) The influence of patient preference on depression treatment in primary care. Ann Behav Med 30:164–173CrossRefPubMed Lin P, Campbell DG, Chaney EF, Liu CF, Heagerty P, Felker BL et al (2005) The influence of patient preference on depression treatment in primary care. Ann Behav Med 30:164–173CrossRefPubMed
60.
Zurück zum Zitat Preference-Collaborative-Review-Group. Patients’ preferences within randomised trials: systematic review and patient level meta-analysis. BMJ 2008;337:a1864 Preference-Collaborative-Review-Group. Patients’ preferences within randomised trials: systematic review and patient level meta-analysis. BMJ 2008;337:a1864
61.
Zurück zum Zitat Howard L, Thornicroft G (2006) Patient preference randomised controlled trials in mental health research. Br J Psychiatry 188:303–304CrossRefPubMed Howard L, Thornicroft G (2006) Patient preference randomised controlled trials in mental health research. Br J Psychiatry 188:303–304CrossRefPubMed
Metadaten
Titel
A mindfulness-based program for improving quality of life among hematopoietic stem cell transplantation survivors: feasibility and preliminary findings
verfasst von
Paul Grossman
Diana Zwahlen
Jorg P. Halter
Jakob R. Passweg
Claudia Steiner
Alexander Kiss
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2452-4

Weitere Artikel der Ausgabe 4/2015

Supportive Care in Cancer 4/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.